Browsing Tag
pharmaceutical
5 posts
Structure Therapeutics (Nasdaq: GPCR) posts 16% weight loss with oral GLP-1 drug aleniglipron, setting up Phase 3 push
Structure Therapeutics' aleniglipron hits 16% weight loss at 44 weeks in Phase 2, matching injectables. Read the full analysis before Phase 3 begins.
Pfizer-backed Priovant wins FDA priority review for brepocitinib in dermatomyositis
FDA grants priority review to Priovant's brepocitinib NDA for dermatomyositis with a Q3 2026 PDUFA date. Read what this means for Roivant, Pfizer, and the autoimmune market.
Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech
In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation…
Zydus Lifesciences announces Punit Patel as new CEO for Americas operations
Global lifesciences firm, Zydus Lifesciences Limited, recently declared the appointment of Punit Patel as the President and Chief…
AstraZeneca wins FDA approval for Tagrisso in adjuvant treatment of early-stage NSCLC patients with EGFR mutations
Find out how AstraZeneca’s expanded FDA approval for Tagrisso is transforming early-stage lung cancer treatment standards.